St. Jude Children’s Research Hospital shared on LinkedIn:
“Inherited changes in DNA can influence cancer risk and understanding that inherited risk can help researchers and clinicians identify opportunities for earlier screening, surveillance and prevention.
Kim Nichols, St. Jude Division of Cancer Predisposition director and Department of Oncology member, studies the genetic factors that contribute to cancer development and progression. Her work connects specialized clinical care and genomic research to improve risk assessment, guide screening strategies and inform future approaches to cancer prevention and treatment.
At St. Jude scientists are uncovering the biological factors that shape inherited cancer risk and using those insights to improve risk assessment, surveillance and prevention strategies.
Nichols said:
‘As we better understand the genetic and biological framework of cancer predisposition, we can begin to think more broadly about how to detect risk earlier and positively change the outcomes for patients and their family members through early detection and prevention, both locally and around the world.
Learn more about The hidden inheritance behind cancer risk and development.”
Other articles about St. Jude Children’s Research Hospital on OncoDaily.
